Efficacy of ruxolitinib in B‐lymphoblastic leukaemia with the PCM1–JAK2 fusion gene
Sign Up to like & getrecommendations! Published in 2021 at "British Journal of Haematology"
DOI: 10.1111/bjh.17340
Abstract: The PCM1–JAK2 fusion gene resulting from a t(8;9)(p22; p24) translocation is a rare genomic abnormality reported in around 40 patients to date. This fusion gene is observed in both myeloid and lymphoid malignancies. The WHO… read more here.
Keywords: pcm1 jak2; fusion gene; jak2 fusion; jak2 ... See more keywords